Efficacy and safety of cefepime-nacubactam and aztreonam-nacubactam compared with imipenem-cilastatin for complicated urinary tract infection or acute uncomplicated pyelonephritis (Integral-1): a double-blind, randomised phase 3 trial. (linkinghub.elsevier.com)

Authors: Takahashi S … Mikamo H Journal: The Lancet Published: 2026-05-16 DOI: https://doi.org/10.1016/S0140-6736(26)00596-9